Capital International’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.67M	Buy	56,066 +547	+1%	+$28.9K	0.1%	132
2025 Q4	$2.91M	Sell	55,519 -6,033	-10%	-$361K	0.1%	131
2025 Q3	$3.99M	Hold	61,552	–	–	0.14%	122
2025 Q2	$2.99M	Sell	61,552 -10,511	-15%	-$407K	0.11%	126
2025 Q1	$2.45M	Sell	72,063 -56,317	-44%	-$2.39M	0.11%	127
2024 Q4	$5.05M	Buy	128,380 +2,776	+2%	+$131K	0.21%	104
2024 Q3	$5.9M	Sell	125,604 -527	-0.4%	-$26.7K	0.25%	95
2024 Q2	$6.81M	Sell	126,131 -639	-0.5%	-$37K	0.31%	81
2024 Q1	$8.64M	Buy	126,770 +31,908	+34%	+$2.28M	0.41%	74
2023 Q4	$5.94M	Sell	94,862 -108	-0.1%	-$5.97K	0.3%	89
2023 Q3	$4.31M	Sell	94,970 -182	-0.2%	-$9.4K	0.25%	102
2023 Q2	$5.34M	Buy	95,152 +2,618	+3%	+$149K	0.3%	94
2023 Q1	$4.19M	Buy	92,534 +14,234	+18%	+$691K	0.25%	110
2022 Q4	$3.18M	Buy	78,300 +2,215	+3%	+$118K	0.22%	115
2022 Q3	$4.97M	Buy	76,085 +27,936	+58%	+$2.02M	0.35%	81
2022 Q2	$2.93M	Buy	48,149 +4,912	+11%	+$289K	0.22%	106
2022 Q1	$2.71M	Hold	43,237	–	–	0.15%	121
2021 Q4	$3.28M	Buy	43,237 +2,838	+7%	+$248K	0.17%	122
2021 Q3	$4.52M	Buy	40,399 +452	+1%	+$56.8K	0.25%	102
2021 Q2	$6.47M	Sell	39,947 -4,451	-10%	-$541K	0.36%	75
2021 Q1	$5.41M	Sell	44,398 -24,951	-36%	-$3.77M	0.33%	90
2020 Q4	$10.6M	Buy	69,349 +916	+1%	+$108K	0.62%	44
2020 Q3	$5.72M	Buy	+68,433	New	+$6.07M	0.39%	66